Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anshen Diwan for Insomnia (Heart-Liver Blood Deficiency)
CTR20221204Phase 3Completed
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Insomnia comparing Anshen Diwan with Placebo (2 arms). Primary endpoint: Pittsburgh Sleep Quality Index (PSQI) total score. Started Jun 2022; status: completed.
02
Drugs
Anshen Diwan
03
Conditions
Insomnia
Beyond the preview
Go deeper on CTR20221204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221204.